426 related articles for article (PubMed ID: 24516168)
1. Hydrogen sulfide cytoprotective signaling is endothelial nitric oxide synthase-nitric oxide dependent.
King AL; Polhemus DJ; Bhushan S; Otsuka H; Kondo K; Nicholson CK; Bradley JM; Islam KN; Calvert JW; Tao YX; Dugas TR; Kelley EE; Elrod JW; Huang PL; Wang R; Lefer DJ
Proc Natl Acad Sci U S A; 2014 Feb; 111(8):3182-7. PubMed ID: 24516168
[TBL] [Abstract][Full Text] [Related]
2. Zofenopril Protects Against Myocardial Ischemia-Reperfusion Injury by Increasing Nitric Oxide and Hydrogen Sulfide Bioavailability.
Donnarumma E; Ali MJ; Rushing AM; Scarborough AL; Bradley JM; Organ CL; Islam KN; Polhemus DJ; Evangelista S; Cirino G; Jenkins JS; Patel RA; Lefer DJ; Goodchild TT
J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27381758
[TBL] [Abstract][Full Text] [Related]
3. Dose-Dependent Effects of Long-Term Administration of Hydrogen Sulfide on Myocardial Ischemia-Reperfusion Injury in Male Wistar Rats: Modulation of RKIP, NF-κB, and Oxidative Stress.
Jeddi S; Gheibi S; Kashfi K; Carlström M; Ghasemi A
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32093102
[TBL] [Abstract][Full Text] [Related]
4. Endothelial Cell Cystathionine γ-Lyase Expression Level Modulates Exercise Capacity, Vascular Function, and Myocardial Ischemia Reperfusion Injury.
Xia H; Li Z; Sharp TE; Polhemus DJ; Carnal J; Moles KH; Tao YX; Elrod J; Pfeilschifter J; Beck KF; Lefer DJ
J Am Heart Assoc; 2020 Oct; 9(19):e017544. PubMed ID: 32990120
[TBL] [Abstract][Full Text] [Related]
5. Hydrogen Sulfide Preserves Endothelial Nitric Oxide Synthase Function by Inhibiting Proline-Rich Kinase 2: Implications for Cardiomyocyte Survival and Cardioprotection.
Bibli SI; Szabo C; Chatzianastasiou A; Luck B; Zukunft S; Fleming I; Papapetropoulos A
Mol Pharmacol; 2017 Dec; 92(6):718-730. PubMed ID: 29030392
[TBL] [Abstract][Full Text] [Related]
6. Hydrogen Sulfide Protects Hyperhomocysteinemia-Induced Renal Damage by Modulation of Caveolin and eNOS Interaction.
Pushpakumar S; Kundu S; Sen U
Sci Rep; 2019 Feb; 9(1):2223. PubMed ID: 30778103
[TBL] [Abstract][Full Text] [Related]
7. Hydrogen sulfide defends against the cardiovascular risk of Nw-nitro-L-argininemethyl ester-induced hypertension in rats via the nitric oxide/endothelial nitric oxide synthase pathway.
Ji W; Liu S; Dai J; Yang T; Jiang X; Duan X; Wu Y
Chin Med J (Engl); 2014; 127(21):3751-7. PubMed ID: 25382331
[TBL] [Abstract][Full Text] [Related]
8. Hydrogen sulfide improves endothelial dysfunction in hypertension by activating peroxisome proliferator-activated receptor delta/endothelial nitric oxide synthase signaling.
Xiao L; Dong JH; Teng X; Jin S; Xue HM; Liu SY; Guo Q; Shen W; Ni XC; Wu YM
J Hypertens; 2018 Mar; 36(3):651-665. PubMed ID: 29084084
[TBL] [Abstract][Full Text] [Related]
9. Hydrogen sulfide donor AP123 restores endothelial nitric oxide-dependent vascular function in hyperglycemia via a CREB-dependent pathway.
Montanaro R; Vellecco V; Torregrossa R; Casillo GM; Manzo OL; Mitidieri E; Bucci M; Castaldo S; Sorrentino R; Whiteman M; Smimmo M; Carriero F; Terrazzano G; Cirino G; d'Emmanuele di Villa Bianca R; Brancaleone V
Redox Biol; 2023 Jun; 62():102657. PubMed ID: 36913800
[TBL] [Abstract][Full Text] [Related]
10. Novel Angiogenic Activity and Molecular Mechanisms of ZYZ-803, a Slow-Releasing Hydrogen Sulfide-Nitric Oxide Hybrid Molecule.
Hu Q; Wu D; Ma F; Yang S; Tan B; Xin H; Gu X; Chen X; Chen S; Mao Y; Zhu YZ
Antioxid Redox Signal; 2016 Sep; 25(8):498-514. PubMed ID: 27174595
[TBL] [Abstract][Full Text] [Related]
11. Hydrogen sulfide improves intestinal recovery following ischemia by endothelial nitric oxide-dependent mechanisms.
Jensen AR; Drucker NA; Khaneki S; Ferkowicz MJ; Markel TA
Am J Physiol Gastrointest Liver Physiol; 2017 May; 312(5):G450-G456. PubMed ID: 28280145
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of intermediate doses of hydrogen sulfide against myocardial ischemia-reperfusion injury in obese type 2 diabetic rats.
Jeddi S; Gheibi S; Kashfi K; Carlström M; Ghasemi A
Life Sci; 2020 Sep; 256():117855. PubMed ID: 32473245
[TBL] [Abstract][Full Text] [Related]
13. Endogenous hydrogen sulfide-mediated MAPK inhibition preserves endothelial function through TXNIP signaling.
Tian D; Dong J; Jin S; Teng X; Wu Y
Free Radic Biol Med; 2017 Sep; 110():291-299. PubMed ID: 28669627
[TBL] [Abstract][Full Text] [Related]
14. Cystathionine γ-Lyase-Produced Hydrogen Sulfide Controls Endothelial NO Bioavailability and Blood Pressure.
Szijártó IA; Markó L; Filipovic MR; Miljkovic JL; Tabeling C; Tsvetkov D; Wang N; Rabelo LA; Witzenrath M; Diedrich A; Tank J; Akahoshi N; Kamata S; Ishii I; Gollasch M
Hypertension; 2018 Jun; 71(6):1210-1217. PubMed ID: 29712741
[TBL] [Abstract][Full Text] [Related]
15. Cystathionine γ-lyase regulates arteriogenesis through NO-dependent monocyte recruitment.
Kolluru GK; Bir SC; Yuan S; Shen X; Pardue S; Wang R; Kevil CG
Cardiovasc Res; 2015 Sep; 107(4):590-600. PubMed ID: 26194202
[TBL] [Abstract][Full Text] [Related]
16. H₂S protects against pressure overload-induced heart failure via upregulation of endothelial nitric oxide synthase.
Kondo K; Bhushan S; King AL; Prabhu SD; Hamid T; Koenig S; Murohara T; Predmore BL; Gojon G; Gojon G; Wang R; Karusula N; Nicholson CK; Calvert JW; Lefer DJ
Circulation; 2013 Mar; 127(10):1116-27. PubMed ID: 23393010
[TBL] [Abstract][Full Text] [Related]
17. Targeting hydrogen sulfide as a promising therapeutic strategy for atherosclerosis.
Xu S; Liu Z; Liu P
Int J Cardiol; 2014 Mar; 172(2):313-7. PubMed ID: 24491853
[TBL] [Abstract][Full Text] [Related]
18. Thymoquinone mitigate ischemia-reperfusion-induced liver injury in rats: a pivotal role of nitric oxide signaling pathway.
Abd-Elbaset M; Arafa EA; El Sherbiny GA; Abdel-Bakky MS; Elgendy AN
Naunyn Schmiedebergs Arch Pharmacol; 2017 Jan; 390(1):69-76. PubMed ID: 27717985
[TBL] [Abstract][Full Text] [Related]
19. The novel H
Testai L; Marino A; Piano I; Brancaleone V; Tomita K; Di Cesare Mannelli L; Martelli A; Citi V; Breschi MC; Levi R; Gargini C; Bucci M; Cirino G; Ghelardini C; Calderone V
Pharmacol Res; 2016 Nov; 113(Pt A):290-299. PubMed ID: 27616550
[TBL] [Abstract][Full Text] [Related]
20. Hydrogen sulfide ameliorated L-NAME-induced hypertensive heart disease by the Akt/eNOS/NO pathway.
Jin S; Teng X; Xiao L; Xue H; Guo Q; Duan X; Chen Y; Wu Y
Exp Biol Med (Maywood); 2017 Dec; 242(18):1831-1841. PubMed ID: 28971696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
